P

Inventor

WELLENZOHN BERND

DE13 patents
⚠️ This page may combine multiple inventors who share the name “WELLENZOHN BERND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOEHRINGER INGELHEIM INT

5 patents
US10501440B2Dec 10, 2019

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

BOEHRINGER INGELHEIM INT4 citations72
US10640486B2May 5, 2020

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

BOEHRINGER INGELHEIM INT4 citations71
US10399961B2Sep 3, 2019

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

BOEHRINGER INGELHEIM INT4 citations71
US11304929B2Apr 19, 2022

Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors

BOEHRINGER INGELHEIM INT0 citations50
US11179371B2Nov 23, 2021

Triazole benzamide derivatives as GPR142 agonists

BOEHRINGER INGELHEIM INT0 citations49

GRAUERT MATTHIAS

2 patents
US8642774B2Feb 4, 2014

Compounds

GRAUERT MATTHIAS5 citations71
US8741892B2Jun 3, 2014

Compounds

GRAUERT MATTHIAS0 citations40

RUDOLF KLAUS

2 patents
US8716277B2May 6, 2014

Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity

RUDOLF KLAUS0 citations50
US8796467B2Aug 5, 2014

Compounds

RUDOLF KLAUS0 citations39

NOSSE BERND

1 patent
US8822471B2Sep 2, 2014

Compounds, pharmaceutical compositions and uses thereof

NOSSE BERND4 citations68

HEIMANN ANNEKATRIN

1 patent
US8883789B2Nov 11, 2014

Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors

HEIMANN ANNEKATRIN2 citations55

FARROW NEIL ALEXANDER

1 patent
US8637550B2Jan 28, 2014

Heteroaryl diamide compounds useful as MMP-13 inhibitors

FARROW NEIL ALEXANDER2 citations54

GOTTSCHLING DIRK

1 patent
US9029360B2May 12, 2015

Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists

GOTTSCHLING DIRK0 citations50